Editorial comment

Editorial

Scott T Tagawa. J Urol. 2009 Sep.

. 2009 Sep;182(3):906.

doi: 10.1016/j.juro.2009.05.110. Epub 2009 Jul 17.

No abstract available

Comment on

Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM. Hellenthal NJ, et al. J Urol. 2009 Sep;182(3):900-6. doi: 10.1016/j.juro.2009.05.011. Epub 2009 Jul 17. J Urol. 2009. PMID: 19616245

[Urologic Oncology Study Society. Promotor and facilitator of uro-oncologic clinical research].
Rexer H, Krege S. Rexer H, et al. Urologe A. 2007 Sep;46(9):1306-13. doi: 10.1007/s00120-007-1506-3. Urologe A. 2007. PMID: 17701155 German. No abstract available.
Editorial comment on: Impact of multimodal treatment on survival in patients with metastatic urothelial cancer.
Bamias A. Bamias A. Eur Urol. 2007 Oct;52(4):1113-4. doi: 10.1016/j.eururo.2007.02.053. Eur Urol. 2007. PMID: 17367916 No abstract available.
[Rational medical therapy for tumors].
Gschwend J. Gschwend J. Urologe A. 2013 Nov;52(11):1515-6. doi: 10.1007/s00120-013-3255-9. Urologe A. 2013. PMID: 24166057 German. No abstract available.
[Time interval between ovarian cancer surgery and chemotherapy--secondary publication?].
Larsen EP, Blaakaer J. Larsen EP, et al. Ugeskr Laeger. 2009 Nov 2;171(45):3265-8. Ugeskr Laeger. 2009. PMID: 19916194 Review. Danish.
Review of adjuvant radiochemotherapy for resected pancreatic cancer and results from Mayo Clinic for the 5th JUCTS symposium.
Miller RC, Iott MJ, Corsini MM. Miller RC, et al. Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):364-8. doi: 10.1016/j.ijrobp.2008.11.069. Int J Radiat Oncol Biol Phys. 2009. PMID: 19735864 Review.